SPPAM
GH icon

Summit Partners Public Asset Management’s Guardant Health GH Stock Holding History

Summit Partners Public Asset Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.3M Buy
+350,000
New +$35.1M 0.87% 39
2020
Q2 		– Sell
-99,800
Closed -$6.95M – 107
2020
Q1 		$6.95M Buy
+99,800
New +$7.66M 0.57% 49
2019
Q4 		– Sell
-120,000
Closed -$7.66M – 89
2019
Q3 		$7.66M Buy
+120,000
New +$10.6M 0.75% 58

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Summit Partners Public Asset Management's GH Position: Q1 2026 in Review

Summit Partners Public Asset Management increased its Guardant Health (GH) stake by 1.3% in Q1 2026, buying an estimated $1.1M and bringing the position to 862,915 shares worth $79.7M. The position accounts for 2.14% of the portfolio, ranked #10.

Summit Partners Public Asset Management first reported a position in GH in Q2 2019 and has held it in 10 quarters since. The position peaked at $87M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Summit Partners Public Asset Management held 862,915 shares of Guardant Health worth $79.7M as of Q1 2026.
  • Summit Partners Public Asset Management bought 10,957 Guardant Health shares in Q1 2026, an estimated $1.1M.
  • Guardant Health made up 2.14% of Summit Partners Public Asset Management's portfolio in Q1 2026, its #10 holding.
  • Summit Partners Public Asset Management first reported a position in Guardant Health in Q2 2019 and has held it in 10 quarters since.
  • Summit Partners Public Asset Management's Guardant Health position peaked at $87M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Summit Partners Public Asset Management's 13F filing for Q1 2026, filed 15 May 2026.